BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16417699)

  • 61. Antenatal screening for Down's syndrome: where are we and where next?
    Haddow JE
    Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914
    [No Abstract]   [Full Text] [Related]  

  • 62. Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009.
    Kazerouni NN; Currier RJ; Flessel M; Goldman S; Hennigan C; Hodgkinson C; Lorey F; Malm L; Tempelis C; Roberson M
    Prenat Diagn; 2011 Sep; 31(9):901-6. PubMed ID: 21706514
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 64. [Screening for Down syndrome in the fetus using maternal blood samples].
    Ryynänen M; Puhakainen E; Laakso M; Suonio S; Saarikoski S
    Duodecim; 1990; 106(21):1431-6. PubMed ID: 1285393
    [No Abstract]   [Full Text] [Related]  

  • 65. Revised distribution parameters for serum markers for trisomy 18.
    Hackshaw AK; Wald NJ
    J Med Screen; 2000; 7(4):215. PubMed ID: 11202590
    [No Abstract]   [Full Text] [Related]  

  • 66. Association of undetectable unconjugated estriol on multiple marker screening with steroid sulfatase deficiency.
    Jari SD; Fraer LM; Hogge WA
    Fetal Diagn Ther; 2004; 19(1):43-8. PubMed ID: 14646417
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The implications of a false positive second-trimester serum screen for Down syndrome.
    Summers AM; Huang T; Meier C; Wyatt PR
    Obstet Gynecol; 2003 Jun; 101(6):1301-6. PubMed ID: 12798540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is ultrasound alone enough for prenatal screening of trisomy 18? A single centre experience in 69 cases over 10 years.
    Lai S; Lau WL; Leung WC; Lai FK; Chin R
    Prenat Diagn; 2010 Nov; 30(11):1094-9. PubMed ID: 20925041
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence rate of Down's syndrome in Karachi resident women.
    Rahman S; Obaid-ur-Rahman M
    Pak J Pharm Sci; 2005 Apr; 18(2):61-3. PubMed ID: 16431402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Choice of serum markers in antenatal screening for Down's syndrome.
    Wald NJ; Watt HC
    J Med Screen; 1994 Apr; 1(2):117-20. PubMed ID: 8790499
    [No Abstract]   [Full Text] [Related]  

  • 71. First-trimester screening for Down's syndrome.
    Wald NJ
    N Engl J Med; 2004 Feb; 350(6):619-21; author reply 619-21. PubMed ID: 14762194
    [No Abstract]   [Full Text] [Related]  

  • 72. Detection of pregnancies with trisomy 18 in screening programmes for Down's syndrome.
    Hackshaw AK; Kennard A; Wald NJ
    J Med Screen; 1995; 2(4):228-9. PubMed ID: 8719154
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy.
    Miron P; Côté YP; Lambert J
    Prenat Diagn; 2008 Mar; 28(3):180-5. PubMed ID: 18264956
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
    Hwa HL; Ko TM; Hsieh FJ; Yen MF; Chou KP; Chen TH
    J Eval Clin Pract; 2007 Apr; 13(2):254-8. PubMed ID: 17378872
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The diagnostic value of the triple test in the diagnosis of Down's syndrome.
    Mol BW; Lok JJ; Voorn W; Pajkrt E; van Lith J; van der Meulen J
    Early Hum Dev; 1996 Dec; 47 Suppl():S55-8. PubMed ID: 9031842
    [No Abstract]   [Full Text] [Related]  

  • 76. Prenatal detection of structural abnormalities of chromosome 18: associations with interphase fluorescence in situ hybridization (FISH) and maternal serum screening.
    Graf MD; Gill P; Krew M; Schwartz S
    Prenat Diagn; 2002 Aug; 22(8):645-8. PubMed ID: 12210569
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical experience with the triple test for Down's syndrome screening.
    Thornton JG; Cartmill RS; Williams J; Holding S; Lilford RJ
    J Perinat Med; 1991; 19(3):151-4. PubMed ID: 1721090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Prenatal screening for Down's syndrome].
    Qin Q; Christiansen M; Norgaard-Pedersen B
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
    [No Abstract]   [Full Text] [Related]  

  • 79. Test pest.
    Hammond P
    Nurs Times; 1994 Aug 10-16; 90(32):60. PubMed ID: 7521958
    [No Abstract]   [Full Text] [Related]  

  • 80. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
    Morris JK; Bestwick J; Wald NJ
    J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.